x
Turning science into breakthroughs
NYU Langone Health and Deerfield Management Company, a New York City-based healthcare investment firm, announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries.
Through a newly formed company called Amethyst Innovations, Deerfield has committed up to $130 million over the next 10 years, along with additional scientific and operational support, including access to the Deerfield-founded Women in Science program, to advance the translation of NYU Langone’s cutting-edge biomedical research in a broad range of areas.
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas and technology in bold, collaborative and inclusive ways. For more information, please visit www.deerfield.com.
NYU Langone Health is one of the nation’s premier academic medical centers, ranked No. 1 in New York and No. 3 in the country on U.S. News & World Report’s “Best Hospitals.” Their trifold mission to serve, teach, and discover is achieved daily through an integrated academic culture devoted to excellence in patient care, education, and research.
NYU Langone’s visionary team is at the forefront of scientific inquiry into pioneering innovations and medical therapies. The institution is among the nation’s top research universities receiving National Institutes of Health (NIH) funding and NYU Langone faculty include many of the world’s leading experts who are guiding the future of biomedical research.
Proposal Submissions
To learn more about project sourcing and evaluation, please reach out to Amethyst Innovations’ Collaboration Director, Gaspar Taroncher-Oldenburg, at gaspar.taroncher-oldenburg@nyulangone.org.
Updates from Cure.
Cure. is a Deerfield affiliate and premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop groundbreaking products and services from concept to commercialization.
Content is generated and provided by third parties, including Cure, an affiliate of Amethyst and Deerfield, and has not been reviewed or approved by Amethyst or Deerfield.